1. Home
  2. XNCR vs USA Comparison

XNCR vs USA Comparison

Compare XNCR & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$24.77

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Liberty All-Star Equity Fund

USA

Liberty All-Star Equity Fund

N/A

Current Price

$5.77

Market Cap

1.8B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
XNCR
USA
Founded
1997
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
XNCR
USA
Price
$24.77
$5.77
Analyst Decision
Buy
Analyst Count
14
0
Target Price
★ $31.42
N/A
AVG Volume (30 Days)
1.0M
★ 1.1M
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 65.36
N/A
EPS
N/A
★ N/A
Revenue
★ $125,576,000.00
N/A
Revenue This Year
$14.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 13.65
N/A
52 Week Low
$10.38
$5.40
52 Week High
$30.61
$6.47

Technical Indicators

Market Signals
Indicator
XNCR
USA
Relative Strength Index (RSI) 51.52 36.86
Support Level $23.36 $5.65
Resistance Level $30.61 $5.90
Average True Range (ATR) 1.03 0.05
MACD -0.09 -0.01
Stochastic Oscillator 55.23 7.50

Price Performance

Historical Comparison
XNCR
USA

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a diversified, closed-end management investment company. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

Share on Social Networks: